Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | -3.23% | -14.29% | -15.49% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-15.49% | 11.67M | |
-5.99% | 84.46B | |
+3.95% | 40.85B | |
-26.18% | 27.69B | |
+53.42% | 24.28B | |
-7.62% | 17.09B | |
-32.37% | 13.67B | |
-16.35% | 11.86B | |
-10.45% | 11.79B | |
-2.55% | 8.07B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Advances to the Efficacy Portion of its Phase 2 Prostate Cancer Trial